2m 2m 2m 2m 2m 2m 2m
Haemonetics (HAE)
NYSE
$72.80+$0.27 (+0.37%)
Price as of Jun 23, 2026 4:10 PM EDT- $3.3BMarket Cap
- 0.64%1-Year Change
- Medical DevicesIndustry
Haemonetics (HAE)
$72.80+$0.27 (+0.37%)
HAE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $72.53 | ||
Change | -$1.64 (-2.21%) | ||
Open | $72.89 | ||
High | $74.26 | ||
Low | $72.45 | ||
Previous Close | $74.17 | ||
Volume | 1,171,854 | ||
30-Day Average Volume | 1,109,135 | ||
1-Week Change | -5.69% | ||
1-Month Change | 10.75% | ||
1-Year Change | 0.64% | ||
3-Year Change | -15.00% | ||
5-Year Change | 13.81% | ||
Fundamentals | |||
Shares Outstanding | 45.4M | ||
Total Assets | $2.4B | ||
Market Cap | $3.3B | ||
Enterprise Value | $4.3B | ||
Period: QTR TTM FY | |||
Revenue | $346.4M | ||
Net Income | -$20.1M | ||
Free Cash Flow | $53.3M | ||
EBIT | -$28.1M | ||
EBITDA | -$780,000.00 | ||
Net Working Capital | $552.3M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -5,481 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 4 | ||
P/E | -167 | ||
PEG | 1 | ||
Price/Free Cash Flow | 62 | ||
Price/Operating Cash Flow | 46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 12/03/2012 | ||
Earnings & Revenue